Log in/ Sign up

About CVXFXS

Convex FXS (CVXFXS) is a cryptocurrency launched in 2023. CVXFXS has a current supply of 6.68M with 0 in circulation. The last known price of CVXFXS is 0.115590101833 USD and is 0 over the last 24 hours. It is currently trading on active market(s) with $0 traded over the last 24 hours. More information can be found at https://www.convexfinance.com/.

Official Website

Social Media

CVXFXS Price Statistics
CVXFXS’s Price Today
24h Price Change
-$00.00%
24h Volume
$00.00%
24h Low / 24h High
$0 / $0
Volume / Market Cap
--
Market Dominance
0.00%
Market Rank
#20712
CVXFXS Market Cap
Market Cap
$0
Fully Diluted Market Cap
$771,834.11
CVXFXS Price History
7d Low / 7d High
$0 / $0
All-Time High
$0
All-Time Low
$0
CVXFXS Supply
Circulating Supply
0
Total Supply
6.68M
Max Supply
0
Updated Sep 02, 2026 3:00 am
image
CVXFXS
Convex FXS
$0.115590101833
$0(-0.00%)
Mkt Cap $0
There's nothing here for now
Thyme Care Raises $125 Million in Series E at More Than $2 Billion Valuation
Thyme Care Raises $125 Million in Series E at More Than $2 Billion Valuation
According to CNBC, Thyme Care raised $125 million in a Series E funding round at a valuation of more than $2 billion, with Morgan Health leading the deal and Humana and CVS Health Ventures among the strategic investors. The company said the round roughly doubled its valuation from a Series D less than a year ago and included AlleyCorp, HealthQuest Capital and a16z Bio + Health. Thyme Care, launched in 2020 and ranked No. 18 on the 2026 CNBC Disruptor 50 list, said it is forming a new parent company called Thyme Companies to build additional businesses focused on gaps in cancer care delivery, access and payment. Robin Shah, who co-founded the company with Bobby Green, will serve as executive chairman of the new entity after stepping down as Thyme Care CEO in July, when Brad Diephuis took over as chief executive. Shah said the first priorities for Thyme Companies will be cancer drug affordability, including faster adoption of lower-cost biosimilars, and improving access and navigation in clinical trials. He said the first of those businesses is expected to launch later this year. Thyme Care said its services reach more than 10.5 million people across all 50 U.S. states, it manages more than $7 billion in oncology spend, and revenue topped $125 million last year, five times the prior year. Shah also said the company is profitable, generating positive free cash flow, and has no near-term IPO plan.
Sep 02, 2026 11:21 pm

Frequently Asked Questions

  • What is the all-time high price of Convex FXS (CVXFXS)?

    The all-time high of CVXFXS was 0 USD on 1970-01-01, from which the coin is now down 0%. The all-time high price of Convex FXS (CVXFXS) is 0. The current price of CVXFXS is down 0% from its all-time high.

    Read More
  • How much Convex FXS (CVXFXS) is there in circulation?

    As of , there is currently 0 CVXFXS in circulation. CVXFXS has a maximum supply of 0.

    Read More
  • What is the market cap of Convex FXS (CVXFXS)?

    The current market cap of CVXFXS is 0. It is calculated by multiplying the current supply of CVXFXS by its real-time market price of 0.115590101833.

    Read More
  • What is the all-time low price of Convex FXS (CVXFXS)?

    The all-time low of CVXFXS was 0 , from which the coin is now up 0%. The all-time low price of Convex FXS (CVXFXS) is 0. The current price of CVXFXS is up 0% from its all-time low.

    Read More
  • Is Convex FXS (CVXFXS) a good investment?

    Convex FXS (CVXFXS) has a market capitalization of $0 and is ranked #20712 on CoinMarketCap. The cryptocurrency market can be highly volatile, so be sure to do your own research (DYOR) and assess your risk tolerance. Additionally, analyze Convex FXS (CVXFXS) price trends and patterns to find the best time to purchase CVXFXS.

    Read More